New software to detect overdose risk among drug users

November 29, 2012, University of St Andrews

A new e-health tool that could help reduce the number of drug-related deaths in Europe will be launched in Brussels today.

The tool, developed by the Orion Project, financed by the European Commission and led by the University of St Andrews, is the first of its kind.  If rolled out successfully, researchers say the tool could help to significantly reduce cases of drug overdose.

Gerald Humphris, Professor of at St Andrews - one of the 4 European research groups involved in the research - said in advance of the launch, "Drug use is one of the major causes of health problems and mortality among young people in Europe and this is a concern for the and regulators alike; this is why we were keen to develop a new tool to detect and raise awareness of the risks of drug overdose.

"The findings from our tests have shown that 45% of patients would consider changing their drug taking behaviour as a result of using the software."

The software is designed to help both patients and medical professionals identify key factors that lead to fatal .

Ms Antigoni Papadopoulou, Member of the European Parliament for Cyprus and convenor of the launch said. "Over the last decade, Europe has experienced about one overdose death every hour.  Europe needs to support more tools and projects like this one that will help policy makers to understand how to prevent and reduce drug demand, particularly among the younger generations."

Representatives from EU Member States are meeting at the to discuss a draft of the EU's drug strategy for 2013-2020. The strategy aims to contribute to a reduction in drug demand use and drug supply within the EU, as well as the health and social risks and harms caused by . The framework of this strategy will serve as basis for two consecutive 4 year EU Drugs Action plans.

Explore further: Bristol-Pfizer anticlot drug gets key EU approval

More information: orion-euproject.com/

Related Stories

Bristol-Pfizer anticlot drug gets key EU approval

November 20, 2012
European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system.

How men's lifestyles double their risk of an early death

June 17, 2011
A University of Sussex psychologist is one of the key authors of a major new report that reveals that death rates of men aged 16-64 is twice that of women in the same age range in the European Union.

Methadone linked to 30 percent of painkiller overdoses

July 4, 2012
The prescription drug methadone is linked to over 30 percent of painkiller overdose deaths, according to a report released by the Centers for Disease Control (CDC) and Prevention Tuesday.

Calls for policy changes as lives put at risk by bureaucracy

February 15, 2012
A European Parliament event to discuss how EU legislation has negatively affected the treatment received by children and adolescents has marked International Childhood Cancer Day - 15th February.

Recommended for you

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

Reclassification recommendations for drug in 'magic mushrooms'

September 26, 2018
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule ...

New study finds concurrent use of prescription drugs and dietary supplements could pose health risks

September 25, 2018
A new University of Hertfordshire study found that using certain over-the-counter herbal medicines and dietary supplements alongside prescription drugs could pose serious health risks, especially amongst older adults.

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.